Established in 1987, the AIDS Clinical Trials Group (ACTG) is the world’s largest and longest running HIV clinical trials network. The ACTG conducts groundbreaking research to improve the treatment of HIV and its co-infections, including tuberculosis and viral hepatitis, as well as its co-morbidities. The ACTG also seeks to advance approaches to ultimately cure HIV.
The amfAR Institute for HIV Cure Research is an innovative, collaborative enterprise based at the ARI. Development of a functional cure would mean that individuals infected with HIV would no longer need lifelong drug treatment to hold the virus in check. As the administrative home of the amfAR Institute, the ARI will coordinate scientific efforts in this final battle against HIV.
TAG is an independent, activist, and community-based research and policy think tank committed to racial, gender, and LGBTQ+ equity; social justice; and liberation, fighting to end HIV, tuberculosis (TB), and hepatitis C virus (HCV).
UCSF's AIDS Research Institute mission is to enhance the effectiveness of UCSF's pioneering HIV enterprise, including research, care and education.
Youth4Cure is a study to discuss motivations, deterrents, and desires to participate in HIV cure research among youth living with HIV (YLWH).
WRI is a program of The Well Project, convened Advancing Meaningful Inclusion of All Women in HIV Research and Clinical Trials on May 12-15, 2022. The meeting sought to address the ways that women are systematically excluded from or under-represented in HIV research and clinical trials and identify solutions to address the underlying issues that perpetuate these inequities.
Martin Delaney Collaboratories Towards an HIV-1 Cure